Blue Cloud Softech Solutions Ltd
Incorporated in 1991, Blue Cloud Softech Solutions Ltd is in the business of computer software and data processing services
- Market Cap ₹ 2,064 Cr.
- Current Price ₹ 22.4
- High / Low ₹ 38.0 / 16.5
- Stock P/E 32.2
- Book Value ₹ 12.3
- Dividend Yield 0.00 %
- ROCE 14.2 %
- ROE 11.6 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Debtor days have increased from 109 to 141 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Software Software Products
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| 502 | 797 | 1,002 | 1,088 | |
| 475 | 726 | 877 | 925 | |
| Operating Profit | 27 | 70 | 125 | 164 |
| OPM % | 5% | 9% | 13% | 15% |
| 0 | 1 | 1 | 1 | |
| Interest | 5 | 8 | 10 | 14 |
| Depreciation | 1 | 4 | 26 | 56 |
| Profit before tax | 21 | 59 | 90 | 94 |
| Tax % | 26% | 25% | 32% | |
| 16 | 44 | 60 | 64 | |
| EPS in Rs | 0.36 | 1.01 | 0.80 | 0.95 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 41% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | -11% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 17% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 44 | 44 | 75 |
| Reserves | 34 | 78 | 848 |
| 68 | 94 | 269 | |
| 48 | 135 | 175 | |
| Total Liabilities | 193 | 351 | 1,367 |
| 52 | 58 | 970 | |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| 141 | 292 | 398 | |
| Total Assets | 193 | 351 | 1,367 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -20 | -13 | 208 | |
| -48 | -11 | -935 | |
| 74 | 20 | 727 | |
| Net Cash Flow | 7 | -4 | 0 |
| Free Cash Flow | -71 | -23 | -730 |
| CFO/OP | -51% | 3% | 187% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 76 | 112 | 141 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 76 | 112 | 141 |
| Working Capital Days | 30 | 51 | 4 |
| ROCE % | 37% | 14% |
Insights
In beta| Mar 2028 (P) | Mar 2029 (P) | Mar 2030 (P) | Mar 2031 (P) | Mar 2032 (P) | |
|---|---|---|---|---|---|
| Data Center Planned Capacity MW |
|
||||
Extracted by Screener AI
Documents
Announcements
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015: Press Release On Listing Of Equity Shares Of The Company On The National Stock Exchange Of India Limited
- Blue Cloud shares admitted to NSE Main Board from 17 August 2026; 92.3 crore shares listed.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Blue Cloud Softech shares admitted to NSE trading from 17 August 2026, alongside BSE listing.
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015.
- Board meets 24 Aug 2026 to consider U.S. healthcare acquisition and preferential fund raising.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2026
- Board approved Q1 FY27 results; completed Rs 372.81 crore Global Impx acquisition and authorised NSE Main Board listing.
-
Board Meeting Intimation for Intimation Of Date Of Board Meeting Pursuant To Regulation 29(1)(A) Of The SEBI (LODR) Regulations, 2015.
- Board meeting on August 14, 2026 to approve Q1 FY27 results; trading window remains closed.
Annual reports
Concalls
-
Jun 2026TranscriptPPTREC
-
Mar 2026TranscriptPPT
Company Overview[1]
The Company operates across high-growth verticals including digital health (BluHealth), AI diagnostics (BluBio), advanced sterilization (BioSter), 5G Fixed Wireless Access (FWA), cybersecurity, and enterprise telecom, supported by a structured SPV-led operating model.